TAM receptors Tyro3 and Mer as novel targets in colorectal cancer

PURPOSE: CRC remains the third most common cancer worldwide with a high 5-year mortality rate in advanced cases. Combined with chemotherapy, targeted therapy is an additional treatment option. However as CRC still escapes targeted therapy the vigorous search for new targets is warranted to increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Robin, Valls, Aida Freire, Yerbes, Rosario, von Richter, Sophie, Kahlert, Christoph, Loges, Sonja, Weitz, Jürgen, Schneider, Martin, de Almodovar, Carmen Ruiz, Ulrich, Alexis, Schmidt, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302919/
https://www.ncbi.nlm.nih.gov/pubmed/27486820
http://dx.doi.org/10.18632/oncotarget.10889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302919/
https://www.ncbi.nlm.nih.gov/pubmed/27486820
http://dx.doi.org/10.18632/oncotarget.10889

Ejemplares similares